It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Off-market insider buying at NeonMind Biosciences ⦠Better Plant Sciences Inc: Better Plant's Neonmind lists on Frankfurt exchange Get NeonMind Biosciences Inc (6UF-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. There is no recent news for this security. For the best MarketWatch.com experience, please update to a modern browser. Vancouver, B.C. View live NEONMIND BIOSCIENCES INC chart to track its stock's price action. Description Better Plant Sciences Inc offers plant-based products for health and wellness. Listing and disclosure documents will be ⦠NeonMind Announces Grants Pursuant to Stock Option Plan. NeonMind Biosciences Inc. is a psychedelic drug development company. Where possible, we have offered a stock quote: please note that these are in USD where possible, for comparative purposes (and thus generally represent the OTC ticker). Current stock quote for NeonMind Biosciences Inc ( C.NEON ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion Sector Healthcare RiskRating. NEONMIND BIOSCIENCES INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share NEONMIND BIOSCIENCES INC. | CANADIAN NATIONAL STOCK EXCHANGE: NEON | CANADIAN NATIONAL STOCK EXCHANGE Of the 5.94 million, 250,000 were granted to directors, 4.9 million were granted to officers and 790,000 were granted to consultants under the company's incentive stock ⦠It also handles research and development for the use of psychedelic substances to ⦠Vancouver, British Columbia--(Newsfile Corp. - December 30, 2020) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), is pleased to announce that it has successfully completed the maximum offering for its initial public offering (the "IPO") of 46,000,000 units of NeonMind (the "Units") at a price to the public of $0.10 per Unit⦠The Company is engaged in developing and commercializing products that contain legal medicinal mushrooms and products that may contain psychedelic compounds. Its brands include Urban Juve, Neonmind Biosciences, Wright and Well, Wright & Well Cbd, Jack and Jane. NeonMind Biosciences Inc stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors. Below is a directory of these psychedelic stocks, in no particular order. The NeonMind Biosciences stock forecast is 10.888725 USD for 2022 January 15, Saturday; and 14.690 USD for 2026 January 15, Thursday with technical analysis. NeonMind Biosciences Inc manufactures Medicinal Mushroom products under the brand NeonMind which are for sale through e-commerce on its website. Sector Healthcare RiskRating. The company was founded by Jeff B. Smith and Penny White on September 18, 2019 and is headquartered in Vancouver, Canada. Vancouver, B.C. December 29, 2020 (Investorideas.com Newswire) The common shares of Neonmind Biosciences Inc. have been approved for listing on the CSE. Copyright © 2021 MarketWatch, Inc. All rights reserved. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Create a list of the investments you want to track. By using this site you agree to the
NeonMind Biosciences, Inc. engages in the manufacture of medicinal mushroom products under the brand NeonMind. It also handles research and development for the use of psychedelic substances to treat compulsive eating, food cravings, provide weight loss benefits and as potential treatment or regulation of diabetes, and regulation of blood glucose, and to reduce susceptibility to cardiovascular disease, high blood pressure, diabetes mellitus, hypertension, multiple sclerosis, erectile dysfunction, urinary incontinence, chronic renal failure, sleep apnea, asthma and certain forms of cancer. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. 6UF | Complete Neonmind Biosciences Inc. stock news by MarketWatch. : Get the latest NeonMind Biosciences stock price and detailed information including news, historical charts and realtime prices. Listing and disclosure documents will be available on the CSE website on the trading date. Numinus (TSXV: NUMI) OTC: LKYSF | USD $1.14 | 0.00% Numinus Wellness is a publicly-traded company that is licensed (via Salvation Botanicals) by Health Canada to test, sell and distribute psychedelic substances. Have Watchlists? Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Listing and disclosure documents will be available at www.thecse.com on the trading date. ... Price/Sales - Latest closing price of the stock divided by the last twelve months ⦠The Company is engaged in developing and commercializing products that contain legal medicinal mushrooms and products that may contain psychedelic compounds. Neonmind Biosciences Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. NeonMind Biosciences Inc. ... at a price of $1.07 per Unit, for aggregate gross proceeds of $11,500,253. Subscriber Agreement & Terms of Use,
The Issuer is conducting research into potentially therapeutic uses of compounds found in psychedelic mushrooms and is commercializing edible … There are currently no items in this Watchlist. Name Clearing account number; mwb fairtrade Wertpapierhandelsbank AG: 1172 A Division of NBCUniversal. It is also in the early stages of development of a product with the goal of using such product to promote and cause weight loss using a compound found in psychedelic mushrooms. Vancouver, British Columbia--(Newsfile Corp. - May 21, 2020) - The Yield Growth Corp. (CSE :BOSS) (OTCQB: BOSQF) (FSE: YG3) majority owned subsidiary NeonMind Biosciences Inc. ("NeonMind… Privacy Notice, and
December 29, 2020 (Investorideas.com Newswire) The common shares of Neonmind Biosciences Inc. have been approved for listing on the CSE. What Is Berkshire Hathaway’s Mystery Stock? View live NEONMIND BIOSCIENCES INC chart to track its stock's price action. Neonmind Biosciences to trade on CSE Jan. 4. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. NeonMind Biosciences Inc. NeonMind Biosciences Inc. is a psychedelic drug development company. All quotes are in local exchange time. Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. NEON | Complete Neonmind Biosciences Inc. stock news by MarketWatch. CSE bulletin 2020-1238 . 2020-12-29 14:20 ET - New Listing. Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. Get Better Plant Sciences Inc (YG3-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. As a result, NeonMind⦠The NeonMind ⦠Lead Broker. The common shares of Neonmind Biosciences Inc. have been approved ⦠Mitchells & Butler plans equity offering as Boris Johnson rules out vaccine passports for pubs, Vivendi shares surge 16% on plan to list Universal Music Group, Reddit crowd succeeds when they target companies with high passive holdings, research finds. NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer. Vancouver, British Columbia--(Newsfile Corp. - January 11, 2021) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), a psychedelic drug development company, granted a â¦